ACRV
Acrivon Therapeutics, Inc.
1.90$
+2.1%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 7.9% | – | – | – | 35.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -7.9% | – | – | – | -35.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 813.6% | – | – | – | 2,161.2% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 295.9% | – | – | – | 745.8% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 1,109.6% | – | – | – | 2,907.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -1,117.5% | – | – | – | -2,942.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 86.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -1,021.9% | – | – | – | -2,692.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 93.9% | – | – | – | -21.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -1,021.9% | – | – | – | -2,692.3% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -1,014.0% | – | – | – | -2,656.6% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.